Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Jubilant Life Sciences to report net profit at Rs. 211.2 crore up 36.3% year-on-year (down 19% quarter-on-quarter). Net Sales are expected to increase by 3.8% Y-o-Y (down 1.7% Q-o-Q) to Rs. 2,336.5 crore.